Publication Date
2015
Journal Title
World J Hepatol
Abstract
Inflammatory bowel disease (IBD) is composed of Crohn's disease and ulcerative colitis and is manifested by both bowel-related and extraintestinal manifestations. Recently the number of therapeutic options available to treat IBD has dramatically increased, with each new medication having its own mechanism of action and side effect profile. A complete understanding of the hepatotoxicity of these medications is important in order to distinguish these complications from the hepatic manifestations of IBD. This review seeks to evaluate the hepatobiliary complications of non-steroid based IBD medications and aide providers in the recognition and management of these side-effects.
Volume Number
7
Issue Number
27
Pages
2716-28
Document Type
Article
EPub Date
2015/12/09
Status
Faculty; Northwell Researcher
Facility
School of Medicine; Northwell Health
Primary Department
Gastroenterology
Additional Departments
Hepatology
PMID
DOI
10.4254/wjh.v7.i27.2716